PubRank

Vinayak Shenoy

Author PubWeight™ 22.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med 2009 2.40
2 Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 2006 2.17
3 Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury. Exp Physiol 2011 1.61
4 Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension 2008 1.56
5 Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer. Hypertension 2009 1.32
6 Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases. Exp Physiol 2010 1.11
7 Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension 2013 1.07
8 Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy. Hypertension 2012 1.05
9 Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology. Exp Physiol 2011 1.04
10 Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors. Diabetes 2012 0.98
11 Angiotensin-converting enzyme 2 activation improves endothelial function. Hypertension 2013 0.98
12 Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction. Regul Pept 2012 0.93
13 Selective tropism of the recombinant adeno-associated virus 9 serotype for rat cardiac tissue. J Gene Med 2010 0.90
14 Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney. Clin Exp Pharmacol Physiol 2013 0.80
15 Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia. J Mol Med (Berl) 2016 0.79
16 Diminazene aceturate improves autonomic modulation in pulmonary hypertension. Eur J Pharmacol 2013 0.78
17 Neuroinflammation in pulmonary hypertension: concept, facts, and relevance. Curr Hypertens Rep 2014 0.78
18 ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy. J Cardiovasc Pharmacol 2015 0.77
19 Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats. Protein Pept Lett 2016 0.77
20 Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury. J Sex Med 2014 0.75